CLINICAL_TRIALS
trial_result
· 2020-12-14
Clinical Trial Update: Open Label Extension of LipoLat-CS202
Summary
Open-label extension study update for LipoLat-CS202 completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peregrine Ophthalmic | Conditions: Glaucoma | Status: COMPLETED | Results posted: 2020-12-14